Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, Life Science Research Center, University of South China, Hengyang, Hunan 421001, China.
Atherosclerosis. 2012 Jun;222(2):344-54. doi: 10.1016/j.atherosclerosis.2012.03.005. Epub 2012 Mar 27.
Pregnancy-associated plasma protein-A (PAPP-A) has been involved in the atherosclerotic process through regulation of local expression of IGF-1 that mediates the activation of the phosphatidylinositol-3 (PI3-K) and Akt kinase (Akt) signaling cascades which lead to constitutive nitric oxide formation, with its attending vasodilator, antiplatelet and insulin-sensitizing actions. In addition, IGF-1 may decreased cholesterol efflux through reductions of expression in ABCA1 and SR-B1 by the PI3-K/Akt signaling pathway. In the current study, we examined whether PAPP-A was involved in LXRα regulation and in expression of ABCA1, ABCG1 or SR-B1 through the IGF-I-mediated signaling pathway (IGF/PI3-K/Akt). Results showed that PAPP-A significantly decreased expression of ABCA1, ABCG1 and SR-BI at both transcriptional and translational levels in a dose-dependent and time-dependent manner. Cellular cholesterol content was increased while cholesterol efflux was decreased by PAPP-A treatment. Moreover, LXRα which can regulate the expression of ABCA1, ABCG1 and SR-B1, was also down-regulated by PAPP-A treatment. LXRα-specific activation by LXRα agonist almost rescued the down-regulation of ABCA1, ABCG1 and SR-B1 expression by PAPP-A. In addition, PAPP-A can induce the IGF-1/PI3-K/Akt pathway in macrophages. Furthermore, our results indicate that the decreased levels observed in LXRα, ABCA1, ABCG1 and SR-B1 mRNA and protein levels upon treating cells with PAPP-A were strongly impaired with the PI3-K inhibitors or IGF-1R siRNA while the MAPK cascade inhibitor did not execute this effect, indicating that the process of ABCA1, ABCG1 and SR-BI degradation by PAPP-A involves the IGF-1/PI3-K/Akt pathway. In conclusion, PAPP-A may first down-regulate expression of LXRα through the IGF-1/PI3-K/Akt signaling pathway and then decrease expression of ABCA1, ABCG1, SR-B1 and cholesterol efflux in THP-1 macrophage-derived foam cells. Therefore, our study provided one of the mechanisms for understanding the critical effect of PAPP-A in pathogenesis of atherosclerosis.
妊娠相关血浆蛋白 A(PAPP-A)通过调节局部 IGF-1 的表达参与动脉粥样硬化过程,IGF-1 介导磷脂酰肌醇-3(PI3-K)和 Akt 激酶(Akt)信号级联的激活,导致持续的一氧化氮形成,随之而来的是血管舒张、抗血小板和胰岛素增敏作用。此外,IGF-1 可能通过 PI3-K/Akt 信号通路降低 ABCA1 和 SR-B1 的表达来减少胆固醇外流。在本研究中,我们研究了 PAPP-A 是否通过 IGF-I 介导的信号通路(IGF/PI3-K/Akt)参与 LXRα 调节以及 ABCA1、ABCG1 或 SR-B1 的表达。结果表明,PAPP-A 以剂量和时间依赖性方式显著降低 ABCA1、ABCG1 和 SR-BI 的转录和翻译水平的表达。PAPP-A 处理增加了细胞内胆固醇含量,同时降低了胆固醇外流。此外,LXRα 可以调节 ABCA1、ABCG1 和 SR-B1 的表达,PAPP-A 处理也下调了 LXRα 的表达。LXRα 激动剂特异性激活几乎挽救了 PAPP-A 下调 ABCA1、ABCG1 和 SR-B1 表达。此外,PAPP-A 可以诱导巨噬细胞中的 IGF-1/PI3-K/Akt 通路。此外,我们的结果表明,在用 PAPP-A 处理细胞后,LXRα、ABCA1、ABCG1 和 SR-B1 mRNA 和蛋白水平观察到的降低水平,用 PI3-K 抑制剂或 IGF-1R siRNA 强烈削弱了这一作用,而 MAPK 级联抑制剂没有执行这一作用,表明 PAPP-A 降解 ABCA1、ABCG1 和 SR-BI 的过程涉及 IGF-1/PI3-K/Akt 通路。总之,PAPP-A 可能首先通过 IGF-1/PI3-K/Akt 信号通路下调 LXRα 的表达,然后降低 THP-1 巨噬细胞源性泡沫细胞中 ABCA1、ABCG1、SR-B1 和胆固醇外流的表达。因此,我们的研究提供了理解 PAPP-A 在动脉粥样硬化发病机制中关键作用的机制之一。